4.1.3.3	Carcinoma, Hepatocellular	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4289103&form=6&db=m	[On the activity of neuraminic acid aldolase and neuraminidase in the cells of ascite and solid forms of hepatoma 22 in mice]	ongoing research,unassigned	4,0	
4.1.3.3	Foot-and-Mouth Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21320350&form=6&db=m	Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli.	ongoing research,therapeutic application,unassigned	1,1,0	
4.1.3.3	Influenza, Human	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15858666&form=6&db=m	Synthesis of screening substrates for the directed evolution of sialic acid aldolase: towards tailored enzymes for the preparation of influenza A sialidase inhibitor analogues.	therapeutic application,unassigned	3,0	
4.1.3.3	Nephrosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13994626&form=6&db=m	[Neuraminic acid aldolase activity in rat kidneys in experimental nephrosis.]	ongoing research,unassigned	2,0	
4.1.3.3	Pasteurella Infections	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15731025&form=6&db=m	Sialic Acid metabolism and systemic pasteurellosis.	unassigned	-	
4.1.3.3	Sialic Acid Storage Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30568043&form=6&db=m	Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function.	causal interaction,unassigned	2,0	
4.1.3.3	Teratocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4065222&form=6&db=m	Sialic acid lyase in differentiating murine teratocarcinoma cells.	causal interaction,unassigned	1,0	
4.1.3.3	Tuberculosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18054225&form=6&db=m	Inhibiting dihydrodipicolinate synthase across species: towards specificity for pathogens?	therapeutic application,unassigned	1,0